Emmanuel CAEYMAEX

Emmanuel CAEYMAEX

Pharma Expert, UCB

Emmanuel CAEYMAEX is Executive Vice President and Immunology Patient Value Unit Head at UCB. He leads the understanding of patient needs, the development and commercialization of solutions. Over the last 20 years Emmanuel has been instrumental in advancing UCB’s transformation into a global biopharma company focused on patients with severe diseases.

We are Theodorus,

THE ULB SPIN-OFF FUND
AND WE ARE LOOKING FORWARD
TO MEETING YOU!